In vitro and in vivo activities of aminoadamantane and aminoalkylcyclohexane derivatives against Trypanosoma brucei

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 5, 2001, Pages 1360-1366

  Kelly, J M ^a   Quack, G ^a   Miles, M M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 ADAMANTYL 4 AMINOCYCLOHEXANE; ALKYL GROUP; AMANTADINE; ANTIVIRUS AGENT; CYCLOHEXYLAMINE DERIVATIVE; RIMANTADINE; UNCLASSIFIED DRUG;

ALKALINITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GROWTH INHIBITION; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARASITEMIA; PH MEASUREMENT; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA BRUCEI;

ADAMANTANE; ANIMALS; CYCLOHEXYLAMINES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS; HYDROGEN-ION CONCENTRATION; MICE; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS;

EID: 0035037935     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.5.1360-1366.2001     Document Type: Article

References (27)

1. Pharmacokinetics of a single dose of rimantadine in young adults and children
2. Safety and pharmacokinetics of rimantadine small-particle aerosol
3. The fall and rise of sleeping sickness
4. Biological potential for amantadine-resistant influenza A virus in an avian model
5. Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells
6. Chemotherapy for leishmaniasis and trypanosomiasis
7. The molecular basis of the specific anti-influenza action of amantadine
8. Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults
9. Comparative single-dose pharmacokinetics of amantadine and rimantadine hydrochloride in young and elderly adults
10. Continuous culture of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers
11. Pharmacokinetics and metabolism of rimantadine hydrochloride in mice and dogs
12. The anti-influenza virus drug rimantadine has trypanocidal activity
13. Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate receptor antagonism
14. Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes
15. The treatment of human African trypanosomiasis
16. Understanding the mechanism of action of the anti-influenza virus drug amantadine
17. Influenza virus M2 protein has ion channel activity
18. Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza A2
19. Changing the end: Variation orchestrated at the telomeres of African trypanosomes
20. Genes involved in phenotypic and antigenic variation in African trypanosomes and malaria
21. How to overcome resistance to influenza A viruses against adamantane derivatives
22. Transport of amantadine and rimantadine through the blood-brain barrier
23. Amantadine selection of a mutant influenza virus containing an acid-stable haemagglutinin glycoprotein: Evidence for virus-specific regulation of the pH of glycoprotein transport vesicles
24. The GPI-phospholipase C of Tryanosoma brucei is nonessential but influences parasitemia in mice
25. Sleeping sickness rediscovered
26. Rimantadine pharmacokinetics after single and multiple doses